Ethical dilemmas in contemporary psychiatry: Findings from a survey of National Psychiatric Associations in Europe.

ethical codes ethics human rights psychiatry

Journal

European psychiatry : the journal of the Association of European Psychiatrists
ISSN: 1778-3585
Titre abrégé: Eur Psychiatry
Pays: England
ID NLM: 9111820

Informations de publication

Date de publication:
01 Nov 2023
Historique:
medline: 6 12 2023
pubmed: 1 11 2023
entrez: 1 11 2023
Statut: epublish

Résumé

The European Psychiatric Association (EPA) is an organization that speaks on behalf of its individual members and members of National Psychiatric Associations (NPAs). The aim of this study to identify and investigate current contents of ethical codes and practices in the countries belonging to EPA. The study is an expert survey sent out to 44 representatives of 30 NPAs covering the following topics: the existence of national bodies dealing with ethical issues in psychiatry, the availability of documents relevant to ethical issues, the types of ethical issues addressed at the national level, and the current and envisaged ethical debates. Out of 44 experts invited to participate in the study, 31 NPAs from 30 countries responded (response rate 70.45%). In the majority of countries, the general mission statement serves as the main document covering ethical issues in psychiatry. Most frequently, internal documents were reported to address medical malpractice, workplace bullying, plagiarism, academic fraud, sexual abuse, and discrimination/racism. Furthermore, internal documents cover the ethical assessment of potentially controversial procedures, including psychosurgery, euthanasia, and pregnancy termination. The most important topics for debate at the level of NPAs/EPA were associated with violations of clinical practice standards and human rights. NPAs are active in the field of professional ethics, defining ethical standards related to interactions among professionals and services provided by mental health care professionals. Future collaboration of NPAs, under the umbrella of the EPA, could allow to develop a database of local ethical documents that would be translated into English and accessible to all EPA members.

Sections du résumé

BACKGROUND BACKGROUND
The European Psychiatric Association (EPA) is an organization that speaks on behalf of its individual members and members of National Psychiatric Associations (NPAs). The aim of this study to identify and investigate current contents of ethical codes and practices in the countries belonging to EPA.
METHODS METHODS
The study is an expert survey sent out to 44 representatives of 30 NPAs covering the following topics: the existence of national bodies dealing with ethical issues in psychiatry, the availability of documents relevant to ethical issues, the types of ethical issues addressed at the national level, and the current and envisaged ethical debates.
RESULTS RESULTS
Out of 44 experts invited to participate in the study, 31 NPAs from 30 countries responded (response rate 70.45%). In the majority of countries, the general mission statement serves as the main document covering ethical issues in psychiatry. Most frequently, internal documents were reported to address medical malpractice, workplace bullying, plagiarism, academic fraud, sexual abuse, and discrimination/racism. Furthermore, internal documents cover the ethical assessment of potentially controversial procedures, including psychosurgery, euthanasia, and pregnancy termination. The most important topics for debate at the level of NPAs/EPA were associated with violations of clinical practice standards and human rights.
CONCLUSIONS CONCLUSIONS
NPAs are active in the field of professional ethics, defining ethical standards related to interactions among professionals and services provided by mental health care professionals. Future collaboration of NPAs, under the umbrella of the EPA, could allow to develop a database of local ethical documents that would be translated into English and accessible to all EPA members.

Identifiants

pubmed: 37909413
doi: 10.1192/j.eurpsy.2023.2470
pii: S0924933823024707
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e94

Auteurs

Jerzy Samochowiec (J)

Department of Psychiatry, Pomeranian Medical University, Szczecin, Poland.

Dorota Frydecka (D)

Department of Psychiatry, Wroclaw Medical University, Wrocław, Poland.

Karolina Skonieczna-Żydecka (K)

Department of Biochemical Science, Pomeranian Medical University, Szczecin, Poland.

Meryam Schouler-Ocak (M)

Psychiatrische Universitätsklinik der Charité Im St. Hedwig Krankenhaus, Berlin, Germany.

Bernardo Carpinello (B)

Section of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Eka Chkonia (E)

Department of Psychiatry, Tbilisi State Medical University, Tbilisi, Georgia.

Geert Dom (G)

Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Antwerp, Belgium.

Peter Falkai (P)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, München, Germany.

Błażej Misiak (B)

Department of Psychiatry, Wroclaw Medical University, Wrocław, Poland.

Mariana Pinto da Costa (M)

Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.

Jan Wise (J)

Adult General Psychiatry CNWL NHS Foundation Trust, London, United Kingdom.

Livia de Picker (L)

University Psychiatric Hospital Campus Duffel, Duffel, Belgium.

Simavi Vahip (S)

Department of Psychiatry, Ege University Medicine Faculty, Affective Disorders Unit, Izmir, Turkey.

Danuta Wasserman (D)

National Centre for Suicide Research and Prevention of Mental Ill-Health, Karolinska Universitet, Stockholm, Sweden.

Silvana Galderisi (S)

Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.

Przemysław Bieńkowski (P)

Department of Psychiatry, Warsaw Medical University, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH